Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Feldman

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Journal of the National Cancer Institute|February 7, 2016
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaFrancesco Sabbatino, Yangyang Wang, Giosuè Scognamiglio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Blood|July 15, 2016
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myelomaSyed Abbas Ali, Victoria Shi, Irina Maric, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functionsPaul F Robbins, Yong F Li, Mona El-Gamil, et al.
Molecular Cancer|June 26, 2023
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturingHyatt Balke-Want, Vimal Keerthi, Nikolaos Gkitsas, et al.
Nature Medicine|June 6, 2018
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancerNikolaos Zacharakis, Harshini Chinnasamy, Mary Black, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Journal of the National Cancer Institute|February 7, 2016
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaFrancesco Sabbatino, Yangyang Wang, Giosuè Scognamiglio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Blood|July 15, 2016
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myelomaSyed Abbas Ali, Victoria Shi, Irina Maric, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functionsPaul F Robbins, Yong F Li, Mona El-Gamil, et al.
Molecular Cancer|June 26, 2023
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturingHyatt Balke-Want, Vimal Keerthi, Nikolaos Gkitsas, et al.
Nature Medicine|June 6, 2018
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancerNikolaos Zacharakis, Harshini Chinnasamy, Mary Black, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Pageof 7